Detalhe da pesquisa
1.
An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics.
Cell
; 173(2): 400-416.e11, 2018 04 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29625055
2.
Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer.
Cell
; 173(2): 291-304.e6, 2018 04 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29625048
3.
Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of origin.
Cell
; 158(4): 929-944, 2014 Aug 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-25109877
4.
Quantifying hormone receptor status in lobular breast cancer in an institutional series: the relationship between estrogen and progesterone receptor status and outcomes.
Breast Cancer Res Treat
; 202(2): 367-375, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37500962
5.
Clinical and molecular characteristics of estrogen receptor-positive ultralow risk breast cancer tumors identified by the 70-gene signature.
Int J Cancer
; 150(12): 2072-2082, 2022 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35179782
6.
Reduced cardiovascular risks in women with endometriosis or polycystic ovary syndrome carrying a common functional IGF1R variant.
Hum Reprod
; 37(5): 1083-1094, 2022 05 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35362533
7.
N-Propargylglycine: a unique suicide inhibitor of proline dehydrogenase with anticancer activity and brain-enhancing mitohormesis properties.
Amino Acids
; 53(12): 1927-1939, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34089390
8.
A risk-associated Active transcriptome phenotype expressed by histologically normal human breast tissue and linked to a pro-tumorigenic adipocyte population.
Breast Cancer Res
; 22(1): 81, 2020 07 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-32736587
9.
Integrated genomic characterization of endometrial carcinoma.
Nature
; 497(7447): 67-73, 2013 May 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-23636398
10.
Tamoxifen therapy benefit for patients with 70-gene signature high and low risk.
Breast Cancer Res Treat
; 166(2): 593-601, 2017 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-28776283
11.
Functional IGF1R variant predicts breast cancer risk in women with preeclampsia in California Teachers Study.
Cancer Causes Control
; 28(10): 1027-1032, 2017 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-28822014
12.
Correction to: N-Propargylglycine: a unique suicide inhibitor of proline dehydrogenase with anticancer activity and brain-enhancing mitohormesis properties.
Amino Acids
; 53(12): 1941, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34286353
13.
Phosphoprotein secretome of tumor cells as a source of candidates for breast cancer biomarkers in plasma.
Mol Cell Proteomics
; 13(4): 1034-49, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24505115
14.
FOXM1 cistrome predicts breast cancer metastatic outcome better than FOXM1 expression levels or tumor proliferation index.
Breast Cancer Res Treat
; 154(1): 23-32, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26456572
15.
mTORC1/C2 and pan-HDAC inhibitors synergistically impair breast cancer growth by convergent AKT and polysome inhibiting mechanisms.
Breast Cancer Res Treat
; 144(2): 287-298, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24562770
16.
First pregnancy events and future breast density: modification by age at first pregnancy and specific VEGF and IGF1R gene variants.
Cancer Causes Control
; 25(7): 859-68, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24801045
17.
Therapeutic targeting of HYPDH/PRODH2 with N-propargylglycine offers a Hyperoxaluria treatment opportunity.
Biochim Biophys Acta Mol Basis Dis
; 1870(1): 166848, 2024 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37586438
18.
Brain transcriptomic, metabolic and mitohormesis properties associated with N-propargylglycine treatment: A prevention strategy against neurodegeneration.
Brain Res
; 1826: 148733, 2024 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38128812
19.
An optimized five-gene multi-platform predictor of hormone receptor negative and triple negative breast cancer metastatic risk.
Breast Cancer Res
; 15(5): R103, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-24172169
20.
FOXP3-positive regulatory T lymphocytes and epithelial FOXP3 expression in synchronous normal, ductal carcinoma in situ, and invasive cancer of the breast.
Breast Cancer Res Treat
; 139(2): 381-90, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23712790